Regeneron Pharmaceuticals Inc (1REGN)
BIT
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 4.86B | 5.87B | 6.71B | 7.86B | 8.78B | 16.12B | 12.26B | 13.12B |
Operating Income | 1.33B | 2.08B | 2.53B | 2.21B | 3.58B | 8.95B | 4.74B | 4.05B |
Pre Tax Income | 1.33B | 2.08B | 2.55B | 2.43B | 3.81B | 9.33B | 4.86B | 4.2B |
Net Income | 895.52M | 1.2B | 2.44B | 2.12B | 3.51B | 8.08B | 4.34B | 3.95B |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 4.178 | 5.324 | 10.705 | 9.492 | 16.246 | 36.757 | 19.582 | 17.951 |
EBIT | 1.34B | 2.1B | 2.58B | 2.34B | 3.67B | 9B | 4.8B | 4.03B |
EBITDA | 1.44B | 2.22B | 2.68B | 2.42B | 3.81B | 9.23B | 5.08B | 4.47B |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.